Latest stories on GILD
Cantor Fitzgerald reiterates Gilead Sciences stock rating at Overweight
Investing.com Analyst Ratings61 · neutralanalyst
Gilead Sciences stock may move 4.3% on August earnings report
Investing.com Markets56 · neutralearnings
ViiV's Dovato as effective as Gilead's Biktarvy in head-to-head trial
Seeking Alpha52 · neutralproduct/pr
J&J, Gilead among recipients of EU drug recommendations this week
Seeking Alpha50 · neutralgeneral
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 | GILD Stock News
StockTitan50 · neutralearnings
Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials
Reuters73 · bullishproduct/pr
Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure | MRK Stock News
StockTitan63 · neutralproduct/pr
Gilead Sciences' Quarterly Earnings Preview: What You Need to Know
Yahoo Finance42 · neutralearnings
Gilead Sciences' Quarterly Earnings Preview: What You Need to Know
Barchart42 · neutralearnings
Gilead downgraded at Leerink on HIV PrEP headwinds
Seeking Alpha34 · bearishanalyst
Gilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors
TipRanks34 · bearishproduct/pr
Final Trade: UNP, SLG, NFLX, GILD
CNBC50 · neutralgeneral
Gilead Targets Long-Acting HIV Regimens With New Injectable Study
TipRanks63 · neutralproduct/pr
Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?
Yahoo Top54 · neutralanalyst
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
The Motley Fool67 · bullishproduct/pr
Morgan Stanley Keeps Buy Rating on Gilead (GILD)
Yahoo Finance61 · neutralanalyst
BBG Advanced Therapies Launches Mobile Leukapheresis Center, in Collaboration with Kite to Bring CAR T-cell Therapies Closer to Patients
Business Insider56 · neutralproduct/pr
Is Gilead (GILD) One of the Most Undervalued NASDAQ Stocks to Buy Right Now?
Yahoo Finance57 · neutralanalyst
Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD) Following Positive HIV Trial Results
Yahoo Top68 · bullishanalyst
Gilead Gets FDA Approval for Treatment for Aggressive Form of Breast Cancer
Morningstar73 · bullishproduct/pr
Gilead's Trodelvy gains new breast cancer indications
Seeking Alpha73 · bullishproduct/pr